Mustafa Turkoz

Head of Immunology at Turn Biotechnologies

Mustafa Turkoz obtained his PhD from Washington University in St. Louis, and did his postdocs at Cincinnati Children's Hospital and Stanford University School of Medicine. He has more than 10 years background in immunology and immuno-oncology space, and more than 5 years in adoptive cell and autologous/allogeneic CAR-T therapies. He specializes in T-cell immunotherapy and cellular immunology to understand and utilize immune cell-based therapies in treatment of cancer and some other immunological disorders. Recently, he is focusing on rejuvenation of immune cells using epigenetic reprogramming to enhance efficacy of adoptive cell and CAR-T therapies in the clinic.